Availability of aldo-keto reductase 1C3 and ATP-binding cassette B1 as therapeutic targets for alleviating paclitaxel resistance in breast cancer MCF7 cells.
J Biochem
; 173(3): 167-175, 2023 Mar 07.
Article
en En
| MEDLINE
| ID: mdl-36413758
Palabras clave
ATP-binding cassette B1; Aldo-keto reductase 1C3 Abbreviations: AKR, aldo-keto reductase; BPS, 3-bromo-5-phenylsalicylic acid; BSO, buthionine sulfoximine; CDDP, cis-diamminedichloroplatinum; CDDP-R, CDDP-resistant MCF7; DPBS, Dulbecco's phosphate-buffered saline; DTNB, 5,5'-dithiobis(2-nitrobenzoic acid); DTX, docetaxel; GCL, glutamate-cysteine ligase; GPx, glutathione peroxidase; GR, glutathione reductase; GSH, reduced glutathione; GSHEE, glutathione ethyl ester; GST, glutathione S-transferase; HNE, 4-hydroxy-2-nonenal; Keap1, Kelch-like ECH associated protein 1; MCA, 4-methylcoumaryl-7-amide; MG132, Z-Leu-Leu-Leu-al; Nrf2, nuclear factor erythroid 2-related factor 2; PCR, polymerase-chain reaction; PG, prostaglandin; ROS, reactive oxygen species; SFN, sulforaphane; siRNA, small-interfering RNA; TOL, tolfenamic acid; UDCA, ursodeoxycholic acid; breast cancer; chemoresistance; docetaxel; paclitaxel
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Paclitaxel
/
Neoplasias
Límite:
Humans
Idioma:
En
Revista:
J Biochem
Año:
2023
Tipo del documento:
Article
País de afiliación:
Japón
Pais de publicación:
Reino Unido